Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analgesic Effect and Safety Analysis of Nalbuphine in ARDS Patients After Surgery

NCT06037330 is registered in ClinicalTrials.gov with Hairong Chen as lead sponsor.

NCT NCT06037330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06037330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analgesic Effect and Safety Analysis of Nalbuphine in ARDS Patients After Surgery
Lead sponsor
Hairong Chen
Phase
Phase 4
Overall status
Recruiting
Start date
September 1, 2023
Completion date
November 30, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome